pharmaceutical investing Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra
medical device investing Arch Therapeutics to Provide Corporate Update at the Maxim Group – Haitong Securities Healthcare Investor and Partnering Conference
Factor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic Wounds
1911 Gold Closes C$13.2 Million "Bought Deal" Life Offering Including Increased Investment by Eric Sprott
